ASD Advanced Simulation & Design GmbH  

ASD  Germany
  ASD Advanced Simulation & Design GmbH
Erich-Schlesinger-Straße 50
D-18059 Rostock
Principal Investigator(s):
  Dr. Catrin Bludszuweit-Philipp

List of researchers and collaborators involved in the project:

  Ms. Karen Lukow
Mr. Felix Winter
Dr. Catrin Bludszuweit-Philipp
  WP1 Clinical Study Design. Clinical Verification of Models and Platforms
WP4 Genetic, Biochemical and Metabolic Pathways Modelling with Environmental Influence
WP5 Multiscale Biophysical & Biochemical Modeling: Brain Substrate and its Evolution
WP7 Biomedical Research Platform for Disease Modelling and Model Personalization
WP9 Technology Assessment, Market Analysis and Exploitation
Main competencies:
Partner ASD Advanced Simulation & Design GmbH (ASD) is an SME focussed on the application of innovative, simulation-based methods primarily to the fields of bioengineering and biotechnology. ASD provides to its customers independent expert solutions for virtual product analysis and optimisation using modern simulation tools. ASD provides specific know-how in the integration of biophysical, biochemical and biological processes into a system-focussed modelling approach. The company has previously participated in the EU-funded projects BloodSim, GEMSS as well as @neurIST and is still active in the EU FP7 ICT project ARTreat. ASD was founded in 1996 and is located in Rostock (Germany). 67% of its highly qualified employees are women.

Contributions to the project
ASD has a long-term expertise and know-how in the complex modelling of coupled biochemical/biophysical systems which will be contributed to the project. A particular area of know-how and international recognition of ASD is the development of innovative simulation tools to predict metabolic activities of cells and functional changes of biological cells. Examples comprise a multi-scale modelling tool for targeted agent release and transport in cell culture systems for tissue engineering and the modelling of the coagulation cascade to predict thrombosis events in the human vascular system. ASD will commit its know-how in the area of system analysis, metabolic activity and biophysical transport modelling to VP-DARE-IT. The company will provide its advanced simulation facilities to the project and will contribute to the further development of simulation techniques within the project.
ASD will lead the “Genetic, Biochemical and Metabolic Pathway Modelling” work package (WP4) and will contribute to the “Multiscale Biophysical & Biochemical Modelling” (WP5).